Abstract

Dr. Tushar B. Shelar* and Dr. Jayvant V. Kharat

ABSTRACT

We are seeing a lot of Mucormycosis cases with and after COVID-19 infection. Post Covid Mucormycosis is an emerging infection associated with high mortality rates. These fungi are very common moulds to which exposure is quite frequent, still a clinical disease is rare and affects severely immunocompromised patients or patients with Diabetes. Mucormycosis is manifested by a wide variety of symptoms such as Rhino, Orbital, Cerebral and Pulmonary infection. Its diagnosis relies on the identification of the organism in the tissue. Early diagnosis may prevent progress of tissue invasion, reduce the need and extent of surgical resection and improve survival.